Trials / Conditions / Combined Hyperlipidemia
Combined Hyperlipidemia
4 registered clinical trials studyying Combined Hyperlipidemia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 NCT06475872 | Hanlim Pharm. Co., Ltd. | Phase 1 |
| Completed | "Phospholipovit" vs Placebo in Patients With Combined Hyperlipidemia NCT05742022 | Institute of Biomedical Chemistry, Russia | Phase 2 / Phase 3 |
| Completed | A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia NCT00459745 | Shionogi | Phase 3 |
| Terminated | Cholesterol-Lowering Effects of Policosanol NCT00288483 | Drug Commission of the German Medical Association | Phase 3 |